The federal government’s endorsement of RBP solidifies its position as a legally viable and effective health care pricing model. Fiduciaries must consider federal regulations, guidance, and legal precedents that support the use of RBP when evaluating its potential benefits. The endorsement by the federal government serves as a strong signal to fiduciaries that RBP is a legitimate and beneficial option for health insurance plans.
Continue reading Fiduciary Responsibility Demands Consideration of Reference-based Pricing (RBP)
